Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohammad Hojjat-Farsangi. (2016) Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances. Journal of Drug Targeting 24:3, pages 192-211.
Read now
Read now
Articles from other publishers (11)
Baishan Jiang, David M. Weinstock, Katherine A. Donovan, Hong-Wei Sun, Ashley Wolfe, Sam Amaka, Nicholas L. Donaldson, Gongwei Wu, Yuan Jiang, Ryan A. Wilcox, Eric S. Fischer, Nathanael S. Gray & Wenchao Wu. (2023) ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas. Cell Chemical Biology 30:4, pages 383-393.e6.
Crossref
Crossref
Yizhou Huang, Lizhi Chen, Ziyi Tang, Yu Min, Wanli Yu, Gangyi Yang & Lili Zhang. (2021) A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study. Frontiers in Endocrinology 12.
Crossref
Crossref
Xueying Wang, Gang Xue & Zhengying Pan. (2020) Design, synthesis and structure–activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK). European Journal of Medicinal Chemistry 187, pages 111918.
Crossref
Crossref
Jared Moore, Kevin Lau, Xiaofeng Xu, Yamin Zhang & Jason D. Burch. (2019) Enantioselective synthesis of GNE-6688, a potent and selective inhibitor of interleukin-2 inducible T-cell kinase (ITK). Tetrahedron Letters 60:11, pages 785-788.
Crossref
Crossref
Marian C. Bryan & Naomi S. Rajapaksa. (2018) Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. Journal of Medicinal Chemistry 61:20, pages 9030-9058.
Crossref
Crossref
Jason D. Burch, Kathy Barrett, Yuan Chen, Jason DeVoss, Charles Eigenbrot, Richard Goldsmith, M. Hicham A. Ismaili, Kevin Lau, Zhonghua Lin, Daniel F. Ortwine, Ali A. Zarrin, Paul A. McEwan, John J. Barker, Claire Ellebrandt, Daniel Kordt, Daniel B. Stein, Xiaolu Wang, Yong Chen, Baihua Hu, Xiaofeng Xu, Po-Wai Yuen, Yamin Zhang & Zhonghua Pei. (2015) Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo. Journal of Medicinal Chemistry 58:9, pages 3806-3816.
Crossref
Crossref
Craig C. Carson, Stergios J. Moschos, Sharon N. Edmiston, David B. Darr, Nana Nikolaishvili-Feinberg, Pamela A. Groben, Xin Zhou, Pei Fen Kuan, Shaily Pandey, Keefe T. Chan, Jamie L. Jordan, Honglin Hao, Jill S. Frank, Dennis A. Hopkinson, David C. Gibbs, Virginia D. Alldredge, Eloise Parrish, Sara C. Hanna, Paula Berkowitz, David S. Rubenstein, C. Ryan Miller, James E. Bear, David W. Ollila, Norman E. Sharpless, Kathleen Conway & Nancy E. Thomas. (2015) IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma. Clinical Cancer Research 21:9, pages 2167-2176.
Crossref
Crossref
Sabine Dondorf, Alexandra Schrader & Marco Herling. (2015) Interleukin-2-inducible T-cell Kinase (ITK) Targeting by BMS-509744 Does Not Affect Cell Viability in T-cell Prolymphocytic Leukemia (T-PLL). Journal of Biological Chemistry 290:16, pages 10568-10569.
Crossref
Crossref
Jason D. Burch, Kevin Lau, John J. Barker, Fred Brookfield, Yong Chen, Yuan Chen, Charles Eigenbrot, Claire Ellebrandt, M. Hicham A. Ismaili, Adam Johnson, Daniel Kordt, Colin H. MacKinnon, Paul A. McEwan, Daniel F. Ortwine, Daniel B. Stein, Xiaolu Wang, Dirk Winkler, Po-Wai Yuen, Yamin Zhang, Ali A. Zarrin & Zhonghua Pei. (2014) Property- and Structure-Guided Discovery of a Tetrahydroindazole Series of Interleukin-2 Inducible T-Cell Kinase Inhibitors. Journal of Medicinal Chemistry 57:13, pages 5714-5727.
Crossref
Crossref
Richard M. Pastor, Jason D. Burch, Steven Magnuson, Daniel F. Ortwine, Yuan Chen, Kelly De La Torre, Xiao Ding, Charles Eigenbrot, Adam Johnson, Marya Liimatta, Yichin Liu, Steven Shia, Xiaolu Wang, Lawren C. Wu & Zhonghua Pei. (2014) Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors. Bioorganic & Medicinal Chemistry Letters 24:11, pages 2448-2452.
Crossref
Crossref
Colin H. MacKinnon, Kevin Lau, Jason D. Burch, Yuan Chen, Jonathon Dines, Xiao Ding, Charles Eigenbrot, Alexander Heifetz, Allan Jaochico, Adam Johnson, Joachim Kraemer, Susanne Kruger, Thomas M. Kr?lle, Marya Liimatta, Justin Ly, Rosemary Maghames, Christian A.G.N. Montalbetti, Daniel F. Ortwine, Yolanda P?rez-Fuertes, Steven Shia, Daniel B. Stein, Giancarlo Trani, Darshan G. Vaidya, Xiaolu Wang, Steven M. Bromidge, Lawren C. Wu & Zhonghua Pei. (2013) Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK). Bioorganic & Medicinal Chemistry Letters 23:23, pages 6331-6335.
Crossref
Crossref